SARS-CoV / SARS-CoV-2 (COVID-19) spike antibody [CR3022-RB]
GTX01556
ApplicationsELISA, Neutralisation/Blocking
Product group Antibodies
ReactivityVirus
TargetS
Overview
- SupplierGeneTex
- Product NameSARS-CoV / SARS-CoV-2 (COVID-19) spike antibody [CR3022-RB]
- Delivery Days Customer9
- ApplicationsELISA, Neutralisation/Blocking
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDCR3022-RB
- Concentration1 mg/ml
- ConjugateUnconjugated
- Gene ID1489668
- Target nameS
- Target descriptionspike glycoprotein
- Target synonymssars2, E2, spike glycoprotein
- HostRabbit
- IsotypeIgG
- Protein IDP59594
- Protein NameSpike glycoprotein
- ReactivityVirus
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC41116161
References
- Nanoparticular CpG-adjuvanted SARS-CoV-2 S1 protein elicits broadly neutralizing and Th1-biased immunoreactivity in mice. Lin HT et al., 2021 Dec 15, Int J Biol MacromolRead this paper

![ELISA analysis of SARS-CoV-2 Spike S1 protein, Sheep Fc tag (blue line) and SARS-CoV-2 Spike S2 protein, Sheep Fc tag (orange line) at concentrations of 5 μg/ml using GTX01555 SARS-CoV / SARS-CoV-2 (COVID-19) spike antibody [CR3022]. A 3-fold serial dilution primary antibody from 125 ng/ml was performed. For detection, a 1:4000 dilution of HRP-labelled anti-human IgG antibody was used.](https://www.genetex.com/upload/website/prouct_img/normal/GTX01555/GTX01555_20200424_ELISA_1_w_23053121_840.webp)
